The new CT scan ordering guide has been added here. It can be directly viewed under Clinical -> Radiology.
Starting August 9th, the hours of operations for CHW Ultrasound will be as follows:
Monday-Friday 6:30 am to 7:30 pm
Saturday 7:00 am to 3:30 pm
Sunday call only
Monday-Friday on-call from 7:30 pm to 6:30 am
Saturday after 3:30pm to Monday morning on-call
Monday-Friday 6:30 am to 3:00pm
Monday-Friday on-call from 3:00 pm to 6:30 am**
Saturday and Sunday on-call only**
***Cardiologist approval needed for STAT call-ins***
For CHW Nuclear Medicine:
Monday-Friday 7:00 am to 4:00 pm
Monday-Friday on-call from 4:00pm to 7:00 pm
Saturday and Sunday call only 7:00am to 7:00pm
Any emergent Nuclear Medicine after hour exams will need to be sent to CHH or CHM.
Did you know that there is a database of all medical devices and the relative safety with MRI? The page can be found at Mrisafety.com. The link will be available through this website “links” menu.
Centegra Hospital-McHenry’s Medical Imaging Department invites you to join them for an Open House showcasing the new Force CT Scanner on Wednesday February 24th from 11:00am – 1:00pm. Appetizer, drinks, and dessert will be served.
Free low dose CT lung cancer screenings have been extended through December 2014
For more information please click Here.
Due to drug manufacturing shortages as reported by the drug vendor, Bracco Diagnostic on May 21, 2014 scheduling of outpatient Hepatobiliary studies, with cholecystokinin (CCK), will be discontinue. . The drug, Kinevac, has no known alternatives, prompting this action.
The Centralized Scheduling Department has been requested to retain a list of patients requiring this test. Once supplies become available, they will coordinate the scheduling of these patients.
Should you have any questions, please feel free to contact me at 815-759-4080.
– John Heinrich – Director, Medical Imaging – CHS
As of January 1, 2014, the state of Illinois will require health facilities that provide mammograms to notify women if they have dense breast in accordance with Senate Bill SB2314. Illinois is one of at least 28 states that either are working on legislation or have already passed it. Minor details of breast density legislation differ by state. For example, Illinois is one of the only three states that currently mandate insurance reimbursement for supplemental screening exams for women with dense breasts. Continue reading
Screening for lung cancer with low-dose CT (LDCT) is available at Centegra Health System!
Lung cancer continues to cause more deaths in the United States among men and women than breast, colorectal and prostate cancers combined
It was reported that in McHenry County, lung cancer is the leading cause of death among men and women ages 45–74 years of age.
The 2011 multicenter National Lung Screening Trial (NLST) demonstrated a 20 percent lung cancer specific mortality benefit in the LDCT screening group.
Centegra began a free LDCT lung cancer screening program for the benefit of your patients and our community in November 2013. To schedule CT lung screening, call 815-334-5566.
Who should be screened?
- Patients ages 55 to 74 with a 30 pack-year history of smoking. This includes people who still smoke or have quit within the past 15 years
- Patients who meet criteria should be screened annually
- Those who have symptoms of a lung condition at the time of screening, such as a new cough or shortness of breath, are not eligible.
- If your patient is a candidate our navigator will contact you for an order.
To help you advise your patients, answer their questions and guide their follow-up care, I am enclosing selected articles of importance that have led to the current guidelines as well as a copy of the guidelines from the National Comprehensive Cancer Network (NCCN), which we are using in our program.
As the lung cancer screening process has only recently begun in earnest in this country and with recent endorsement for screening using LDCT by the US Preventative Services Task Force (USPSTF), I expect rapid evolution of guidelines in the near future as various other professional societies publish their opinions.
If you have any questions or comments about the LDCT lung cancer screening program at Centegra, please do not hesitate to contact John J. Guido, MD @ 815-759-4262.
Freedom from smoking classes are offered at several times throughout the year at Centegra Health Bridge Fitness Centers in Crystal Lake and Huntley as well as Centegra Hospital-McHenry. For more information or to register, call 877-CENTEGRA (877-236-8347).
- Patient information on lung cancer screening from NCCN
- Information for clinicians on lung cancer screening from NCCN
- Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer; The National Lung Screening Trial Research Team; N Engl J Med 2013; 368:1980-1991May 23, 2013DOI: 10.1056/NEJMoa1209120
- Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement; Virginia A. Moyer, MD, MPH, on behalf of the U.S. Preventive Services Task Force; Ann Intern Med. 2014;160(5):330-338-338. doi:10.7326/M13-2771
- Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force; Harry J. de Koning et al; Ann Intern Med. 2014;160(5):311-320-320. doi:10.7326/M13-2316
The ACR Manual on Contrast Media  recommends the following options for premedication in the acute setting in patients undergoing planned contrast enhanced imaging procedure (e.g. CT Pulmonary Angiogram). Options #1 or #2 should be used in all Emergency Department situations unless there is an extreme urgency.
IV steroids have not been shown to be effective when administered less than 4 to 6 hours prior to contrast injection
In Decreasing Order of Desirability
- Methylprednisolone sodium succinate (Solu-Medrol®) 200 mg intravenously every 4 hours (q4h) until contrast study required plus diphenhydramine 50 mg IV 1 hour prior to contrast injection .
- Dexamethasone sodium sulfate (Decadron®) 7.5 mg or betamethasone 6.0 mg intravenously q4h until contrast study must be done in patent with known allergy to methylpred-nisolone, aspirin, or non-steroidal anti-inflammatory drugs, especially if asthmatic. Also diphenhydramine 50 mg IV 1hour prior to contrast injection.
- Omit steroids entirely and give diphenhydramine 50 mg IV.
Any patient with creatinine level of 2.0 mg/dL or less and/or eGFR of 30 ml/min or greater can have CTPA to evaluate for PE without undue risk of CIN